251 related articles for article (PubMed ID: 25491510)
21. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
24. Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells.
Wazir U; Sanders AJ; Wazir A; Baig RM; Jiang WG; Ster IC; Sharma AK; Mokbel K
Oncol Rep; 2015 Mar; 33(3):1450-8. PubMed ID: 25530065
[TBL] [Abstract][Full Text] [Related]
25. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
Yang XL; Liu KY; Lin FJ; Shi HM; Ou ZL
Oncol Rep; 2017 Sep; 38(3):1393-1401. PubMed ID: 28713975
[TBL] [Abstract][Full Text] [Related]
26. SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation.
Wang D; Wu P; Wang H; Zhu L; Zhao W; Lu Y
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27780891
[TBL] [Abstract][Full Text] [Related]
27. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
[TBL] [Abstract][Full Text] [Related]
28. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
29. Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway.
Yu B; Gao W; Zhou H; Miao X; Chang Y; Wang L; Xu M; Ni G
Cancer Biomark; 2018 Feb; 21(3):513-519. PubMed ID: 29103019
[TBL] [Abstract][Full Text] [Related]
30. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
Yang X; Sun Y; Li H; Shao Y; Zhao D; Yu W; Fu J
Oncotarget; 2017 Apr; 8(16):26154-26168. PubMed ID: 28412731
[TBL] [Abstract][Full Text] [Related]
31. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
32. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
33. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
[TBL] [Abstract][Full Text] [Related]
34. ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway.
Qu Y; Hao C; Xu J; Cheng Z; Wang W; Liu H
Mol Med Rep; 2017 Oct; 16(4):5036-5042. PubMed ID: 28791358
[TBL] [Abstract][Full Text] [Related]
35. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.
Adam MG; Matt S; Christian S; Hess-Stumpp H; Haegebarth A; Hofmann TG; Algire C
Cell Cycle; 2015; 14(23):3734-47. PubMed ID: 26654769
[TBL] [Abstract][Full Text] [Related]
36. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
37. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
[TBL] [Abstract][Full Text] [Related]
38. Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer.
Bhutia SK; Behera B; Nandini Das D; Mukhopadhyay S; Sinha N; Panda PK; Naik PP; Patra SK; Mandal M; Sarkar S; Menezes ME; Talukdar S; Maiti TK; Das SK; Sarkar D; Fisher PB
Int J Cancer; 2016 Jul; 139(2):457-66. PubMed ID: 26914517
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells.
Xie J; Yan Y; Liu F; Kang H; Xu F; Xiao W; Wang H; Wang Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 29769411
[TBL] [Abstract][Full Text] [Related]
40. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.
Wolf I; Levanon-Cohen S; Bose S; Ligumsky H; Sredni B; Kanety H; Kuro-o M; Karlan B; Kaufman B; Koeffler HP; Rubinek T
Oncogene; 2008 Nov; 27(56):7094-105. PubMed ID: 18762812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
